Download Free Sample Report

The global Immunotherapy market was valued at US$ 188.6 billion in 2023 and is projected to reach US$ 355.3 billion by 2030, at a CAGR of 8.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report studies the Immunotherapy market, covering market size for segment by type (Monoclonal Antibodies, Vaccines, etc.), by application (Cancer, Infectious Diseases, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AbbVie, Merck, Pfizer, Roche, Bristol-Myers Squibb, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Immunotherapy from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Immunotherapy market.

Leading Players of Immunotherapy including:

• AbbVie
• Merck
• Pfizer
• Roche
• Bristol-Myers Squibb
• GlaxoSmithKline
• Novartis
• Johnson & Johnson
• Amgen
• Biogen

Market split by Type:

• Monoclonal Antibodies
• Vaccines
• Others

Market split by Application:

• Cancer
• Infectious Diseases
• Autoimmune Diseases
• Others

Market split by Sales Channel:

• Direct Channel
• Distribution Channel

Market split by Region/Country:

• North America (United States and Canada)
• Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
• South America (Brazil, Mexico, and Argentina, etc.)
• Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.